Maxwell Sensors Inc (“MSI”), our name
derived from our work to MAXimize WELLness
through the design of advanced biomolecular
testing systems, is a California-based
biomedical research and development company
founded in 1998.
MSI’s mission is to develop and
commercialize miniaturization, integration, and
total automation technology for biomedical
MSI commits itself to research and
development of high quality biomedical testing
systems to enhance screening and diagnostics in
the medical industry, serving both established
and emerging markets.
Growth - Improving Function with
MSI has grown to be a key player in R&D
of high performance, automated novel tools
designed to simplify, accelerate and improve
screening, diagnostic and monitoring diseases,
pharmaceutical drug screening, and environmental
monitoring systems in compliance with the FDA’s
quality criteria. Our company has
enjoyed enormous success in securing grants
development partnerships with government,
academic and private organizations to drive
innovation in its areas of interest.
We credit our success to our highly
talented and experienced team of scientific and
business professionals who have earned a solid
reputation in the biomedical industry as
developers of “cost-effective products that do
not compromise quality”.
Today - Chemiluminescence Leader
MSI is one of the world’s leading
innovators in the field of chemiluminescence.
We are currently focused on developing
next generation technologies and products using
an interdisciplinary team of scientists in the
fields of molecular biology, immunoassay,
physics, optics, chemistry, electrical and
mechanical engineering. MSI also maintains an
extensive collaborative network with
universities, government laboratories, and
industrial partners. This approach enables us to
extract optimum efficiency and resources and
leverage those advantages to help our clients
maximize the benefit of our powerful tools.
In addition to sensor development, MSI
pursues research and development of custom
systems for government and commercial contracts.
Our clients include government agencies,
universities and biomedical companies in both
domestic and international market sectors.